Outcomes of additional BCG versus sequential gemcitabine + docetaxel in BCG-exposed high-risk non–muscle-invasive bladder cancer.

Authors: Behzad Jazayeri, Christopher Guske, Christian Harrs, Adnan Nazir Fazili, Lexiaochuan Wen, Hongzhi Xu, Logan Zemp, Alice Yu, Scott Michael Gilbert, Michael Adam Poch, Philippe E. Spiess, Wade J. Sexton, Joshua Linscott, Roger Li

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16600

Source: Full article

---

Abstract

e16600